Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.

The drug is not approved in COVID-19 but is marketed under the brand name PegiHep for treatment of hepatitis B and C. According to a COVID-19 therapy tracker from the Milken Institute think ...

The American Gastroenterology Association (AGA) issued a new clinical guideline recommending antiviral drugs for patients at ...

The American Gastroenterological Association (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation ...

Autoimmune hepatitis recurs after transplantation in ... and for 3 months after, drug withdrawal to detect relapse. Repeat laboratory assessments thereafter at 6–month intervals, then every ...

2. Talk with your doctor about medications and supplements Before starting hepatitis C treatment, tell your doctor about any prescription and over-the-counter medications you take. Be sure to ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

The drug has been granted Breakthrough Therapy designation by the FDA for the treatment of chronic hepatitis delta (CHD).

Privately-held US biopharma Bluejay Therapeutics has announced that its lead product candidate brelovitug—also known as BJT-778—has received US Food and Drug Administration Breakthrough Therapy ...

Repurposing current drugs to tackle dementia is an ‘urgent priority’, academics say, but other experts warn more work is ...